Events/Research Canada presents: “Cancer Gone: The Research and Innovation That Thinks it Can”

April 29, 2021

Research Canada presents: “Cancer Gone: The Research and Innovation That Thinks it Can”

Time: 12:00 am - 11:00 pm

Cancer is a complex disease since it is not one but many diseases: there are over 200 different types of cancer. It can also be quick, elusive and can evolve rapidly, which makes it difficult to treat. Thanks to research, we’ve made some amazing progress in recent years. In the 1940s, survival was about 25%. Today, some types of cancer that historically had poor outcomes now see five-year survival rates surpassing 70, 80 and even 90%. And advancements keep coming.

Canada has been a major research contributor, and thanks to Canadian discoveries made in collaboration with collaborators around the world, we have an improved understanding of what causes cancer, how it develops, how best to treat it and how we can improve the quality of life of people living with cancer, which has been translated into new therapies and diagnostics.

CNL looks forward to participating in this Virtual Reception will feature 24 of Canada’s best and brightest scientists who will share research and innovations in the areas of Early Cancer Detection at Initial Diagnosis and Prior to Progression and Relapse, The Role of Precision Medicine and Immunotherapy in Cancer Research, Pediatric and Adolescent Cancers, and Cancer Prevention.

Research Canada is a national alliance dedicated to increasing investments in health research and support for its related innovation through collaborative advocacy and engaging government, academia, industry and the non-profit sector to build support for long-term health research funding. For more information, visit rc-rc.ca.

About the Speaker

Edouard Azzam , Researcher, Health Sciences

Edouard works with a dedicated team in unravelling the mechanisms underlying the biochemical changes induced in cells and tissues exposed to low doses/low fluences of different radiation types. The goal is to contribute knowledge focussed at alleviating the uncertainty in predicting the health outcomes of occupational exposures, whether in the nuclear industry and health sector or during deep space exploration. Ongoing projects also examine how low dose radiation effects can be harnessed to enhance the effectiveness of cancer therapeutics and in regenerative medicine. He is particularly interested in studying the roles of oxidative metabolism and intercellular communication in radiation-induced adaptive and bystander responses.